These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 24317118)

  • 1. Regulatory T cell proliferative potential is impaired in human autoimmune disease.
    Carbone F; De Rosa V; Carrieri PB; Montella S; Bruzzese D; Porcellini A; Procaccini C; La Cava A; Matarese G
    Nat Med; 2014 Jan; 20(1):69-74. PubMed ID: 24317118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
    Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P
    J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid suppression of cytokine transcription in human CD4+CD25 T cells by CD4+Foxp3+ regulatory T cells: independence of IL-2 consumption, TGF-beta, and various inhibitors of TCR signaling.
    Oberle N; Eberhardt N; Falk CS; Krammer PH; Suri-Payer E
    J Immunol; 2007 Sep; 179(6):3578-87. PubMed ID: 17785792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCL11 increases the proportion of CD4+CD25+Foxp3+ Treg cells and the production of IL‑2 and TGF‑β by CD4+ T cells via the STAT5 signaling pathway.
    Wang R; Huang K
    Mol Med Rep; 2020 Jun; 21(6):2522-2532. PubMed ID: 32323817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo maintenance of human regulatory T cells during CD25 blockade.
    Huss DJ; Mehta DS; Sharma A; You X; Riester KA; Sheridan JP; Amaravadi LS; Elkins JS; Fontenot JD
    J Immunol; 2015 Jan; 194(1):84-92. PubMed ID: 25416807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta.
    Scholzen A; Mittag D; Rogerson SJ; Cooke BM; Plebanski M
    PLoS Pathog; 2009 Aug; 5(8):e1000543. PubMed ID: 19680449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-15 augments TCR-induced CD4+ T cell expansion in vitro by inhibiting the suppressive function of CD25 High CD4+ T cells.
    Van Belle TL; Dooms H; Boonefaes T; Wei XQ; Leclercq G; Grooten J
    PLoS One; 2012; 7(9):e45299. PubMed ID: 23028916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL4 promoted the production of CD4
    Xu T; Zhao J; Wang X; Meng Y; Zhao Z; Bao R; Deng X; Bian J; Yang T
    Autoimmunity; 2020 Aug; 53(5):289-296. PubMed ID: 32538218
    [No Abstract]   [Full Text] [Related]  

  • 9. Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants.
    De Rosa V; Galgani M; Porcellini A; Colamatteo A; Santopaolo M; Zuchegna C; Romano A; De Simone S; Procaccini C; La Rocca C; Carrieri PB; Maniscalco GT; Salvetti M; Buscarinu MC; Franzese A; Mozzillo E; La Cava A; Matarese G
    Nat Immunol; 2015 Nov; 16(11):1174-84. PubMed ID: 26414764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T cells fail to suppress CD4T+-bet+ T cells in relapsing multiple sclerosis patients.
    Frisullo G; Nociti V; Iorio R; Patanella AK; Caggiula M; Marti A; Sancricca C; Angelucci F; Mirabella M; Tonali PA; Batocchi AP
    Immunology; 2009 Jul; 127(3):418-28. PubMed ID: 19016907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In active relapsing-remitting multiple sclerosis, effector T cell resistance to adaptive T(regs) involves IL-6-mediated signaling.
    Schneider A; Long SA; Cerosaletti K; Ni CT; Samuels P; Kita M; Buckner JH
    Sci Transl Med; 2013 Jan; 5(170):170ra15. PubMed ID: 23363979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
    Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
    J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cord blood derived CD4+ CD25(high) T cells become functional regulatory T cells upon antigen encounter.
    Mayer E; Bannert C; Gruber S; Klunker S; Spittler A; Akdis CA; Szépfalusi Z; Eiwegger T
    PLoS One; 2012; 7(1):e29355. PubMed ID: 22272233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced interaction between SEC2 mutant and TCR Vβ induces MHC II-independent activation of T cells via PKCθ/NF-κB and IL-2R/STAT5 signaling pathways.
    Fu X; Xu M; Song Y; Li Y; Zhang H; Zhang J; Zhang C
    J Biol Chem; 2018 Dec; 293(51):19771-19784. PubMed ID: 30352872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells.
    Gomez-Rodriguez J; Wohlfert EA; Handon R; Meylan F; Wu JZ; Anderson SM; Kirby MR; Belkaid Y; Schwartzberg PL
    J Exp Med; 2014 Mar; 211(3):529-43. PubMed ID: 24534190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
    Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
    Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T-cell expansion and function do not account for the impaired alloreactivity of ex vivo-expanded T cells.
    Montcuquet N; Mercier-Letondal P; Perruche S; Duperrier A; Couturier M; Bouchekioua A; Bonyhadi M; Ferrand C; Tiberghien P; Robinet E
    Immunology; 2008 Nov; 125(3):320-30. PubMed ID: 18445006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Lipopolysaccharide-Induced Inflammation Lowers IL-2R Signaling and the Proliferative Potential of Regulatory T Cells.
    Hsiung S; Moro A; Ban Y; Chen X; Savio AS; Hernandez R; Malek TR
    Immunohorizons; 2020 Dec; 4(12):809-824. PubMed ID: 33334814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A distal Foxp3 enhancer enables interleukin-2 dependent thymic Treg cell lineage commitment for robust immune tolerance.
    Dikiy S; Li J; Bai L; Jiang M; Janke L; Zong X; Hao X; Hoyos B; Wang ZM; Xu B; Fan Y; Rudensky AY; Feng Y
    Immunity; 2021 May; 54(5):931-946.e11. PubMed ID: 33838102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective cell cycle induction by IL-2 in naive T-cells antigen stimulated in the presence of refractory T-lymphocytes.
    Inaba H; Geiger TL
    Int Immunol; 2006 Jul; 18(7):1043-54. PubMed ID: 16702166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.